curare
Small moleculemarketed
Approved
Jun 1, 1887
Curare is a common name for various alkaloid arrow poisons originating from plant extracts. Used as a paralyzing agent by indigenous peoples in Central and South America for hunting and for therapeutic purposes, curare only becomes active when it contaminates a wound or is introduced directly to the bloodstream; it is not active when ingested orally. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jun 1, 2012 (NCT01628952)
Timeline
1880s
- Jun 1, 1887
Evidence of US Marketing
Indications
Approved for
Studied for
Mechanism of action
- Neuronal acetylcholine receptorINHIBITOR
Neuronal acetylcholine receptor inhibitor
- Neuronal acetylcholine receptor subunit beta-2 (CHRNB2) ↗
- Neuronal acetylcholine receptor subunit alpha-5 (CHRNA5) ↗
- Neuronal acetylcholine receptor subunit beta-4 (CHRNB4) ↗
- Neuronal acetylcholine receptor subunit alpha-3 (CHRNA3) ↗
- Neuronal acetylcholine receptor subunit alpha-7 (CHRNA7) ↗
- Neuronal acetylcholine receptor subunit alpha-4 (CHRNA4) ↗
- Neuronal acetylcholine receptor subunit beta-3 (CHRNB3) ↗
- Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2) ↗
- Neuronal acetylcholine receptor subunit alpha-6 (CHRNA6) ↗
- Neuronal acetylcholine receptor subunit alpha-10 (CHRNA10) ↗
- Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) ↗
- Neuronal acetylcholine receptor; alpha2/beta2
- Neuronal acetylcholine receptor; alpha9/alpha10
- Neuronal acetylcholine receptor subunit alpha-6/alpha-3
- Neuronal acetylcholine receptor; alpha6/beta2
- Neuronal acetylcholine receptor protein alpha-7 subunit
- Neuronal acetylcholine receptor protein alpha-9 subunit
- Neuronal acetylcholine receptor protein beta-2 subunit
- Neuronal acetylcholine receptor; alpha4/beta2
- Neuronal acetylcholine receptor; alpha4/beta4
- Nicotinic acetylcholine receptor alpha3/beta4/alpha5
- Neuronal acetylcholine receptor; alpha3/beta4
- Nicotinic acetylcholine receptor alpha3/beta2/alpha5
- Neuronal acetylcholine receptors; alpha-3/beta-4, alpha-5, beta-2
- Nicotinic acetylcholine receptor alpha6/alpha3/beta4
- Nicotinic acetylcholine receptor alpha4/beta2/alpha5
- Neuronal acetylcholine receptor protein alpha-4 subunit
- Neuronal acetylcholine receptor subunit alpha-3
- Neuronal acetylcholine receptor; alpha2/beta4
- Neuronal acetylcholine receptor; alpha3/beta2
- Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3
- Neuronal acetylcholine receptor protein alpha-10 subunit
Approval history
- approvedJun 1, 1887
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCurare ↗
Also known as
- curare
- curare
- curare
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02505841 | N/A | May 1, 2015 | University of Montpellier |
| NCT01628952 | Phase 4 | Jun 1, 2012 | University of Picardie Jules Verne |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Montpellier | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Picardie Jules Verne | Academic/Hospital | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1